Skip to main content
SpringerLink
Log in

2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Masaki Y, Kawabata H, Fujimoto S, Kawano M, Iwaki N, Kotani T, et al. Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Exp Hematop. 2019 (in press)

  2. Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016;91:220–6.

    Article  CAS  Google Scholar 

  3. Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, et al. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol. 2019;94:975–83.

    Article  CAS  Google Scholar 

  4. Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103(6):686–92.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported in part by grants from the Ministry of Health, Labor and Welfare, Japan (H29 Nanchi, etc. (Nan)-General-019, H27-28 Nanchi, etc. (Nan)-General-002 and -008), and by the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant No.17591060 and 15K09510), the Kanazawa Medical University Research Foundation (Grant Nos. S2004-16 and S2007-5), Grant for Assist KAKEN from Kanazawa Medical University (Grant No. K2011-7), Grant for Project Research from High-Tech Research Center of Kanazawa Medical University (Grant No. H2011-11) and Grant for Alumni Research(A) from Kanazawa Medical University (AR2012-06).

Author information

Authors and Affiliations

  1. Department of Hematology and Immunology, Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa, 920-0293, Japan

    Yasufumi Masaki, Hiroshi Kawabata & Shino Fujimoto

  2. Division of Hematology, Niigata City General Hospital, Niigata, Japan

    Kazue Takai

  3. Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Japan

    Norifumi Tsukamoto

  4. Medical Research Institute, Kanazawa Medical University, Uchinada, Kahoku-gun, Japan

    Yasuhito Ishigaki

  5. Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Kahoku-gun, Japan

    Nozomu Kurose

  6. Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

    Katsuhiro Miura

  7. Department of Pathology and Biological Response, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Shigeo Nakamura

  8. Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan

    Sadao Aoki

Authors
  1. Yasufumi Masaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Kawabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazue Takai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Norifumi Tsukamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shino Fujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasuhito Ishigaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nozomu Kurose
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katsuhiro Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shigeo Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sadao Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Japanese TAFRO Syndrome Research Team

Corresponding author

Correspondence to Yasufumi Masaki.

Ethics declarations

Conflict of interest

YM has received research grants from Kyowa Hakko Kirin Pharma, Astellas Pharma, Eisai Pharma, Ono Pharma, Pfizer Pharma, Asahi Kasei Pharma, MSD Pharma, Daiichi-Sankyo Pharma, Taisho Pharma, Taiho Pharma, Takeda Pharma, Chugai Pharma, Teijin Pharma, Nippon Kayaku, and Mochida Pharma, outside the submitted work. All other authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masaki, Y., Kawabata, H., Takai, K. et al. 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol 111, 155–158 (2020). https://doi.org/10.1007/s12185-019-02780-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-019-02780-1

Search

Navigation